Dyne Therapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Dyne Therapeutics Inc had 676.11M in cash and cash equivalents.

Dyne Therapeutics Inc reported 214.83M in total liabilities as of the latest reported quarter, including 50.62M in current liabilities and 164.20M in non-current liabilities.

As of the latest reported quarter, Dyne Therapeutics Inc's total assets were 1.19B, consisting of 1.13B in current assets and 60.37M in non-current assets.

Dyne Therapeutics Inc reported 972.13M in total shareholders' equity as of the latest reported quarter.